Team:ULB-Brussels/Safety
From 2014.igem.org
m |
m |
||
Line 23: | Line 23: | ||
<!-- --> | <!-- --> | ||
$\newcommand{\Tgo}{\Large\mathcal{T}\normalsize} | $\newcommand{\Tgo}{\Large\mathcal{T}\normalsize} | ||
- | \newcommand{\MyColi}{{Mighty Coli | + | \newcommand{\MyColi}{{\small Mighty Coli \normalsize }}$ |
- | + | ||
<section style="text-align: justify; margin: 100px"> | <section style="text-align: justify; margin: 100px"> | ||
<p><!--$\Large\mathcal{T}\normalsize$--> | <p><!--$\Large\mathcal{T}\normalsize$--> | ||
- | $\ | + | $\Tgo \hspace{-2cm}$The main concerns raised by <i>Mighty Coli</i> depend more of the protein that we chose to produce than of <i>Mighty Coli</i> in itself. However, <i>Mighty Coli</i> could compel an escaped recombinant bacterium to produce an industrial protein in the environment, when a bacterium without the $\MyColi$ system would quickly degenerate to stop producing the protein of industrial interest. The risk seems thin, since such an overproducing bacterium would suffer from a clear competitive disadvantage in a wild environment, but it is not excluded that the plasmid containing the $\MyColi$ system maintains itself anyway through Horizontal Gene transfer (HGT), at the expend of the wild bacteria it infects, benefiting of the proprieties of the TA system.</p> |
<section style="text-align: justify; margin: 20px"></section> | <section style="text-align: justify; margin: 20px"></section> |
Revision as of 07:35, 11 September 2014
$~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ \newcommand{\MyColi}{{\small Mighty\hspace{0.12cm}Coli}} \newcommand{\Stabi}{\small Stabi}$ $\newcommand{\EColi}{\small E.coli} \newcommand{\SCere}{\small S.cerevisae}\\[0cm] ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ \newcommand{\PI}{\small PI}$ $\newcommand{\Igo}{\Large\mathcal{I}} \newcommand{\Tgo}{\Large\mathcal{T}} \newcommand{\Ogo}{\Large\mathcal{O}} ~$
|
---|